Select Page

UW group ends drug firm funds

A University of Wisconsin School of Medicine and Public Health organization that has been criticized for its advocacy of controversial uses of narcotic painkillers says it has decided to stop taking money from the drug industry. UW made the announcement after an April 3 investigative report in the Journal Sentinel revealed that its UW Pain & Policy Studies Group had taken about $2.5 million over a decade from companies that make opioids. (MILWAUKEE JOURNAL SENTINEL, 4/21)
To access this content, you must purchase a Premium membership, or log in if you are a member.

STAY INFORMED ON THE STATE’S MOST PRESSING HEALTHCARE ISSUES AND INITIATIVES.

Subscribe here for a FREE 14 day trial of our daily news roundup.

You have Successfully Subscribed!

Pin It on Pinterest